Back to feed
SNDXSyndax Pharmaceuticals, Inc.
CIK 0001395937 · no recent filings · 0 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$0
0 sell transactions
Net flow
+$0
Net buying
Total flow
$0
0 priced transactions
Disclosure radarcross-source convergence
Divergent1/5 sources
Recent disclosures · timeline
- Form 1442h ago
Proposed sale of 32,375 sh ($752.4K) · discretionary
Price · SNDX
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
Proposed sales · Form 144
selling intent · live SEC data1 notice$752.4K proposed to sell0/1 under a 10b5-1 plan
| Filed | Filer | Shares | Est. value | Approx. sale | Source of shares | Plan |
|---|---|---|---|---|---|---|
| 2h ago | MICHAEL METZGER Director, Officer | 32,375 | $752.4K | Jul 08, 2026 | Exercise of Stock Options | Discretionary |
Recent insider transactions
No insider transactions recorded for SNDX.